Strength
25 mg/mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00143951910
Classification
Generic
Dosage Form
SOLUTION
Route
INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS
Last Updated
4/22/2026
Active Ingredients
METHOTREXATEApproval Type
Generic (ANDA)
FDA Application
ANDA089340On Market Since
10/10/2017
Pharmacological Classes
Folate Analog Metabolic Inhibitor
Folic Acid Metabolism Inhibitors
Related Drugs
Same classification
METHOTREXATE 2.5 MG TABLET
Generic
00054455025•Hikma Pharmaceuticals USA Inc.
$0.1605
per EA
METHOTREXATE 2.5 MG TABLET
Generic
00378001401•Mylan Pharmaceuticals Inc.
$0.1605
per EA
METHOTREXATE 2.5 MG TABLET
Generic
47335023583•Sun Pharmaceutical Industries Inc.
$0.1605
per EA
METHOTREXATE 2.5 MG TABLET
Generic
47335023596•Sun Pharmaceutical Industries Inc.
$0.1605
per EA
METHOTREXATE 2.5 MG TABLET
Generic
51079067005•Mylan Institutional LLC
$0.1605
per EA
METHOTREXATE 2.5 MG TABLET
Generic
62332073031•Alembic Pharmaceuticals Inc.
$0.1605
per EA
METHOTREXATE 2.5 MG TABLET
Generic
62332073036•Alembic Pharmaceuticals Inc.
$0.1605
per EA
METHOTREXATE 2.5 MG TABLET
Generic
64850033001•Elite Laboratories, Inc.
$0.1605
per EA
METHOTREXATE 250 MG/10 ML VIAL
Generic
63323012310•Fresenius Kabi USA, LLC
$3.3484
per ML